Nabucox (Nabumetone)

Nabumetone, the active ingredient in Nabucox, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adult patients.

GNH USA supplies Nabucox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution, ensuring product integrity throughout the supply chain.

Nabumetone, marketed as Nabucox, is an NSAID that reduces inflammation in musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and stiffness, improving functional mobility. - Rheumatoid arthritis: decreases synovial inflammation and pain, helping to preserve joint function. - Ankylosing spondylitis: reduces spinal inflammation and associated discomfort, supporting better posture and movement. - Acute pain: provides rapid relief of short‑term musculoskeletal pain episodes.

Nabumetone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Peptic ulcer disease: gastrointestinal bleeding or perforation. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe hypersensitivity: angioedema, bronchospasm or anaphylaxis. - Renal impairment: acute kidney injury or worsening chronic kidney disease.

When prescribing Nabucox, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: evaluate creatinine clearance before initiating therapy. - Monitor hepatic status: check liver enzymes periodically during treatment. - Use lowest effective dose: limit exposure to reduce gastrointestinal toxicity. - Avoid in patients with active ulcer disease: consider alternative therapy. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Nabumetone can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function. - Diuretics: heightened risk of renal impairment. - Lithium: NSAIDs can increase lithium serum concentrations.